Glaukos glaucoma net sales $67.2M up 20% year on year.
Their idose TR is really expensive you would think that would lose market share to cheaper options down the track as long as they have similar efficacy
Glaukos glaucoma net sales $67.2M up 20% year on year.Their...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $52.62M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.5¢ | $122.6K | 535.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 95000 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 5633 | 3 |
View Market Depth
| Last trade - 14.25pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
22.5¢ |
Change
-0.010 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.0¢ | 22.5¢ | 283026 | ||
| Last updated 15.12pm 18/06/2024 ? | |||||
| EYE (ASX) Chart |